T. Barba, “Efficacy and safety of infliximab therapy in refractory upper respiratory tract sarcoidosis: experience from the STAT registry”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 34, no. 4, pp. 343–351, Feb. 2018, doi: 10.36141/svdld.v34i4.5817.